Skip to main content
FoodRecallWatch
Class II, May Cause HarmF-0978-2023

Bacaolinita Liquid Dietary Supplement With vitamins A and D + B12 8 fl. oz (236 mL) UPC 841548000028 packaged in a bottle inside a cardboard box

Recalled by Procaps S.a. de C.v. on May 19, 2023

Reviewed by FoodRecallWatch Editorial Team · Updated

Recall Summary

Procaps S.a. de C.v. recalled Bacaolinita Liquid Dietary Supplement With vitamins A and D + B12 8 fl. oz (236 mL) UPC 841548000028 packaged in a bottle inside a cardboard in a Class II action, the FDA tier for products that may cause temporary or medically reversible health effects on May 19, 2023.

The FDA listed the reason as an undeclared allergen: "PEG-40 not declared as an ingredient on the label" Allergen mislabeling is the leading cause of U.S. food recalls, because a missing declaration can trigger a reaction in someone who reads the label and believes the product is safe.

The product reached multiple states, recorded by the FDA as "DE, TX, CA." A multi-state footprint means the same lot can surface in households far from the producer. The recalling firm is based in Soyapango. The recall covers 33,684 Boxes of product. The FDA has Terminated this recall (first reported Jun 14, 2023), its final lifecycle state, indicating the agency considers the corrective action resolved. The historical record remains useful for tracking a brand's recall pattern over time.

Reason for Recall

PEG-40 not declared as an ingredient on the label

Product Description

Bacaolinita Liquid Dietary Supplement With vitamins A and D + B12 8 fl. oz (236 mL) UPC 841548000028 packaged in a bottle inside a cardboard box

Distribution

DE, TX, CA

What Should You Do?

  • 1.Check your kitchen for this product immediately.
  • 2.Do not consume the recalled product.
  • 3.Return the product to where you bought it for a full refund, or throw it away.
  • 4.If you have experienced any health issues, contact your healthcare provider.

Browse Related Recalls

Food category: Dietary Supplements
States affected: California, Delaware, Texas

Terms Explained

Source: FDA Recalls, Market Withdrawals and Safety Alerts, 2026.